MeiraGTx Shares Rise After Presentation of Two Novel Inherited Retinal Disease (IRD) Programs and Riboswitch Gene Regulation Platform
MeiraGTx Holdings plc (NASDAQ: MGTX) stock jumped about 10% after the clinical stage gene therapy company announced three poster presentations at the European Society of Gene and Cell Therapy (ESGCT) 2021 Annual Congress. Two pre-clinical programs addressing Inherited Retinal Diseases...